Endometriosis Therapies Market Report

China Endometriosis Therapies Industry Market Research Report 2023-2029

  • POSTDATE：Aug 20, 2023
  • PAGES：184
  • REPORT CODE：GMM1744832
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • Endometriosis is very painful and can lead to infertility. It affects the outline tissue of the uterus and causes internal bleeding and inflammation. The global endometriosis market size is expected to expand by 2025. Symptoms of endometriosis are, for example, pain before and during the menstrual period, pain during ovulation and irregular or massive bleeding over some time, resulting in a significant reduction in the working female population. High prevalence, unknown etiology, and high productivity loss are the main factors that have led many research institutions and drug manufacturers to research the best diagnosis and treatment of the disease.

    Gonadotropin-releasing hormone agonists, oral contraceptives, and progestin therapy are widely used for pain after diagnosis. The market share of non-steroidal anti-inflammatory drugs accounts for the major share of the global endometriosis market and is expected to maintain its dominant position. The supply of a large number of brands and generic products is expected to drive the growth of market segments soon.

    In developed and developing countries, the increase in the female population aged 15-49 years is expected to drive the growth of the endometriosis drug market. It is expected that the high prevalence of endometriosis among women of childbearing age will drive the market demand for endometriosis treatment in the next few years. The growth of the female population during childbearing age, women's awareness of this disease continues to increase, and the development of new drugs for the treatment of endometriosis are some of the factors that have contributed to market growth. However, it takes more than seven years to diagnose the disease, and the lack of non-invasive diagnostic tests will increase patient suffering. Therefore, this factor may inhibit the growth of the endometriosis therapy market. Also, many important manufacturers are conducting extensive research in the development of advanced drugs and treatments for endometriosis, taking into account cost management, and such initiatives will drive market growth.

    This report elaborates on the current development of the Endometriosis Therapies industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    By Player:

    • Neurocrine Biosciences

    • Bayer

    • Pfizer

    • AbbVie

    • Meditrina Pharmaceuticals

    • Eli Lilly

    • Astellas Pharma

    • Takeda Pharmaceutical

    By Type:

    • Gonadotropin-releasing Hormone (Gn-RH) Agonists

    • Hormonal Contraceptives

    • Aromatase Inhibitors

    • Progestin Therapy

    By Application:

    • Hospital

    • Clinic

    • Other

    By Research Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    Chapter 1 China Endometriosis Therapies Market Overview 2018-2029

    • 1.1 China Endometriosis Therapies Industry Development Overview

    • 1.2 China Endometriosis Therapies Industry Development History

    • 1.3 China Endometriosis Therapies Industry Market Size (2018-2029)

    • 1.4 China Endometriosis Therapies Market Analysis by Type from Production Side

      • 1.4.1 China Endometriosis Therapies Production Volume, Production Value and Growth Rate of Gonadotropin-releasing Hormone (Gn-RH) Agonists (2018-2029)

      • 1.4.2 China Endometriosis Therapies Production Volume, Production Value and Growth Rate of Hormonal Contraceptives (2018-2029)

      • 1.4.3 China Endometriosis Therapies Production Volume, Production Value and Growth Rate of Aromatase Inhibitors (2018-2029)

      • 1.4.4 China Endometriosis Therapies Production Volume, Production Value and Growth Rate of Progestin Therapy (2018-2029)

    • 1.5 China Endometriosis Therapies Market Analysis by Application from Consumption End

      • 1.5.1 China Endometriosis Therapies Sales Volume, Sales Value and Growth Rate of Hospital (2018-2029)

      • 1.5.2 China Endometriosis Therapies Sales Volume, Sales Value and Growth Rate of Clinic (2018-2029)

      • 1.5.3 China Endometriosis Therapies Sales Volume, Sales Value and Growth Rate of Other (2018-2029)

    • 1.6 China Endometriosis Therapies Market Analysis by Region

      • 1.6.1 North China Endometriosis Therapies Market Size and Growth Rate from 2018-2029

      • 1.6.2 Central China Endometriosis Therapies Market Size and Growth Rate from 2018-2029

      • 1.6.3 South China Endometriosis Therapies Market Size and Growth Rate from 2018-2029

      • 1.6.4 East China Endometriosis Therapies Market Size and Growth Rate from 2018-2029

      • 1.6.5 Northeast China Endometriosis Therapies Market Size and Growth Rate from 2018-2029

      • 1.6.6 Southwest China Endometriosis Therapies Market Size and Growth Rate from 2018-2029

      • 1.6.7 Northwest China Endometriosis Therapies Market Size and Growth Rate from 2018-2029

    Chapter 2 China Endometriosis Therapies Industry Development Environment

    • 2.1 Industry Development Environment Analysis

      • 2.1.1 Industry Technological Progress Analysis

      • 2.1.2 Industrial Organizational Innovation Analysis

      • 2.1.3 Changes in Social Habits

      • 2.1.4 Alterations in Government Policies

      • 2.1.5 Impact of Economic Globalization

    • 2.2 Domestic and Foreign Industry Competition Analysis

      • 2.2.1 Comparative Analysis on Endometriosis Therapies Market Status and Competition at home and abroad in 2023

      • 2.2.2 China Endometriosis Therapies Market Status and Competition Analysis in 2023

      • 2.2.3 China Endometriosis Therapies Market Concentration Analysis in 2023

    • 2.3 Problems and Countermeasures in the development of China Endometriosis Therapies Industry

      • 2.3.1 Industry Development Constraints

      • 2.3.2 Industry Development Considerations

      • 2.3.3 Suggestions on Industry Development Measures

      • 2.3.4 Development Strategies for SMEs

    • 2.4 Influence of COVID-19 Outbreak on Endometriosis Therapies Industry Development

    Chapter 3 Endometriosis TherapiesIndustry Chain Analysis

    • 3.1 Endometriosis Therapies Industry Chain

    • 3.2 Endometriosis Therapies Upstream Industry Analysis

      • 3.2.1 Upstream Industry Development Status

      • 3.2.2 Upstream Industry Development Forecast

      • 3.2.3 Impact of Upstream Industry on the Endometriosis Therapies Market

    • 3.3 Endometriosis Therapies Downstream Industry Analysis

      • 3.3.1 Downstream Industry Development Status

      • 3.3.2 Downstream Industry Development Forecast

      • 3.3.3 Impact of Downstream Industry on the Endometriosis Therapies Market

    Chapter 4 China Endometriosis Therapies Market, by Type

    • 4.1 China Endometriosis Therapies Market Trend, by Type

    • 4.2 Product Types of Major Suppliers

    • 4.3 Competitive Landscape of Major Types

    • 4.4 China Endometriosis Therapies Total Production Volume and Growth Rate from Production Side

    • 4.5 China Endometriosis Therapies Production Volume and Growth Rate, by Type

      • 4.5.1 China Endometriosis Therapies Production Volume and Growth Rate of Gonadotropin-releasing Hormone (Gn-RH) Agonists

      • 4.5.2 China Endometriosis Therapies Production Volume and Growth Rate of Hormonal Contraceptives

      • 4.5.3 China Endometriosis Therapies Production Volume and Growth Rate of Aromatase Inhibitors

      • 4.5.4 China Endometriosis Therapies Production Volume and Growth Rate of Progestin Therapy

    Chapter 5 China Endometriosis Therapies Market, by Application

    • 5.1 Downstream Market Overview

    • 5.2 Competitive Landscape of Major Applications

    • 5.3 Market Potential Analysis, by Application

    • 5.4 China Endometriosis Therapies Total Market Size and Growth Rate from Consumption End

    • 5.5 China Endometriosis Therapies Market Size and Growth Rate, by Application

      • 5.5.1 China Endometriosis Therapies Market Size and Growth Rate of Hospital

      • 5.5.2 China Endometriosis Therapies Market Size and Growth Rate of Clinic

      • 5.5.3 China Endometriosis Therapies Market Size and Growth Rate of Other

    Chapter 6 China Endometriosis Therapies Market, by Region

    • 6.1 China Endometriosis Therapies Production Volume and Production Value, by Region

    • 6.2 China Endometriosis Therapies Sales Volume and Sales Value, by Region

    Chapter 7 North China Endometriosis Therapies Market Analysis

    • 7.1 North China Endometriosis Therapies Market, by Type

    • 7.2 North China Endometriosis Therapies Market, by Application

    Chapter 8 Central China Endometriosis Therapies Market Analysis

    • 8.1 Central China Endometriosis Therapies Market, by Type

    • 8.2 Central China Endometriosis Therapies Market, by Application

    Chapter 9 South China Endometriosis Therapies Market Analysis

    • 9.1 South China Endometriosis Therapies Market, by Type

    • 9.2 South China Endometriosis Therapies Market, by Application

    Chapter 10 East China Endometriosis Therapies Market Analysis

    • 10.1 East China Endometriosis Therapies Market, by Type

    • 10.2 East China Endometriosis Therapies Market, by Application

    Chapter 11 Northeast China Endometriosis Therapies Market Analysis

    • 11.1 Northeast China Endometriosis Therapies Market, by Type

    • 11.2 Northeast China Endometriosis Therapies Market, by Application

    Chapter 12 Southwest China Endometriosis Therapies Market Analysis

    • 12.1 Southwest China Endometriosis Therapies Market, by Type

    • 12.2 Southwest China Endometriosis Therapies Market, by Application

    Chapter 13 Northwest China Endometriosis Therapies Market Analysis

    • 13.1 Northwest China Endometriosis Therapies Market, by Type

    • 13.2 Northwest China Endometriosis Therapies Market, by Application

    Chapter 14 Company Profiles

      • 14.1 Neurocrine Biosciences

        • 14.1.1 Neurocrine Biosciences Company Profile

        • 14.1.2 Neurocrine Biosciences Endometriosis Therapies Market Performance

        • 14.1.3 Product&Service Introduction

      • 14.2 Bayer

        • 14.2.1 Bayer Company Profile

        • 14.2.2 Bayer Endometriosis Therapies Market Performance

        • 14.2.3 Product&Service Introduction

      • 14.3 Pfizer

        • 14.3.1 Pfizer Company Profile

        • 14.3.2 Pfizer Endometriosis Therapies Market Performance

        • 14.3.3 Product&Service Introduction

      • 14.4 AbbVie

        • 14.4.1 AbbVie Company Profile

        • 14.4.2 AbbVie Endometriosis Therapies Market Performance

        • 14.4.3 Product&Service Introduction

      • 14.5 Meditrina Pharmaceuticals

        • 14.5.1 Meditrina Pharmaceuticals Company Profile

        • 14.5.2 Meditrina Pharmaceuticals Endometriosis Therapies Market Performance

        • 14.5.3 Product&Service Introduction

      • 14.6 Eli Lilly

        • 14.6.1 Eli Lilly Company Profile

        • 14.6.2 Eli Lilly Endometriosis Therapies Market Performance

        • 14.6.3 Product&Service Introduction

      • 14.7 Astellas Pharma

        • 14.7.1 Astellas Pharma Company Profile

        • 14.7.2 Astellas Pharma Endometriosis Therapies Market Performance

        • 14.7.3 Product&Service Introduction

      • 14.8 Takeda Pharmaceutical

        • 14.8.1 Takeda Pharmaceutical Company Profile

        • 14.8.2 Takeda Pharmaceutical Endometriosis Therapies Market Performance

        • 14.8.3 Product&Service Introduction

    Chapter 15 Research Conclusions and Investment Suggestions

    • 15.1 Endometriosis Therapies Industry Research Conclusions

    • 15.2 Endometriosis Therapies Industry Investment Suggestions

      • 15.2.1 Suggestions on Industry Development Strategy

      • 15.2.2 Suggestions on Industry Investment Direction

      • 15.2.3 Suggestions on Industry Investment Strategy


    List of Tables and Figures

    • Figure China Endometriosis Therapies Industry Market Size (2018-2029)

    • Figure China Endometriosis Therapies Production Volume, Production Value and Growth Rate of Gonadotropin-releasing Hormone (Gn-RH) Agonists (2018-2029)

    • Figure China Endometriosis Therapies Production Volume, Production Value and Growth Rate of Hormonal Contraceptives (2018-2029)

    • Figure China Endometriosis Therapies Production Volume, Production Value and Growth Rate of Aromatase Inhibitors (2018-2029)

    • Figure China Endometriosis Therapies Production Volume, Production Value and Growth Rate of Progestin Therapy (2018-2029)

    • Figure China Endometriosis Therapies Sales Volume, Sales Value and Growth Rate of Hospital (2018-2029)

    • Figure China Endometriosis Therapies Sales Volume, Sales Value and Growth Rate of Clinic (2018-2029)

    • Figure China Endometriosis Therapies Sales Volume, Sales Value and Growth Rate of Other (2018-2029)

    • Figure North China Endometriosis Therapies Market Size and Growth Rate from 2018-2029

    • Figure Central China Endometriosis Therapies Market Size and Growth Rate from 2018-2029

    • Figure South China Endometriosis Therapies Market Size and Growth Rate from 2018-2029

    • Figure East China Endometriosis Therapies Market Size and Growth Rate from 2018-2029

    • Figure Northeast China Endometriosis Therapies Market Size and Growth Rate from 2018-2029

    • Figure Southwest China Endometriosis Therapies Market Size and Growth Rate from 2018-2029

    • Figure Northwest China Endometriosis Therapies Market Size and Growth Rate from 2018-2029

    • Figure Endometriosis Therapies Industry Chain

    • Table Product Types of Major Suppliers in 2023

    • Figure China Endometriosis Therapies Market Share by Type in 2018

    • Figure China Endometriosis Therapies Market Share by Type in 2023

    • Figure China Endometriosis Therapies Total Production Volume and Growth Rate from Production Side (2018-2023)

    • Figure China Endometriosis Therapies Production Volume and Growth Rate of Gonadotropin-releasing Hormone (Gn-RH) Agonists (2018-2023)

    • Figure China Endometriosis Therapies Production Volume and Growth Rate of Hormonal Contraceptives (2018-2023)

    • Figure China Endometriosis Therapies Production Volume and Growth Rate of Aromatase Inhibitors (2018-2023)

    • Figure China Endometriosis Therapies Production Volume and Growth Rate of Progestin Therapy (2018-2023)

    • Figure China Endometriosis Therapies Market Share by Application in 2018

    • Figure China Endometriosis Therapies Market Share by Application in 2023

    • Figure China Endometriosis Therapies Total Market Size and Growth Rate from Consumption End

    • Figure China Endometriosis Therapies Market Size and Growth Rate of Hospital (2018-2023)

    • Figure China Endometriosis Therapies Market Size and Growth Rate of Clinic (2018-2023)

    • Figure China Endometriosis Therapies Market Size and Growth Rate of Other (2018-2023)

    • Table China Endometriosis Therapies Production Volume by Region (2018-2023)

    • Table China Endometriosis Therapies Production Volume Share by Region (2018-2023)

    • Figure China Endometriosis Therapies Production Volume Share by Region (2018-2023)

    • Table China Endometriosis Therapies Production Value by Region (2018-2023)

    • Table China Endometriosis Therapies Production Value Share by Region (2018-2023)

    • Figure China Endometriosis Therapies Production Value Share by Region (2018-2023)

    • Table China Endometriosis Therapies Sales Volume by Region (2018-2023)

    • Table China Endometriosis Therapies Sales Volume Share by Region (2018-2023)

    • Figure China Endometriosis Therapies Sales Volume Share by Region (2018-2023)

    • Table China Endometriosis Therapies Sales Value by Region (2018-2023)

    • Table China Endometriosis Therapies Sales Value Share by Region (2018-2023)

    • Figure China Endometriosis Therapies Sales Value Share by Region (2018-2023)

    • Table North China Endometriosis Therapies Production Volume by Type (2018-2023)

    • Table North China Endometriosis Therapies Production Volume Share by Type (2018-2023)

    • Figure North China Endometriosis Therapies Production Volume Share by Type (2018-2023)

    • Table North China Endometriosis Therapies Sales Volume by Application (2018-2023)

    • Table North China Endometriosis Therapies Sales Volume Share by Application (2018-2023)

    • Figure North China Endometriosis Therapies Sales Volume Share by Application (2018-2023)

    • Table Central China Endometriosis Therapies Production Volume by Type (2018-2023)

    • Table Central China Endometriosis Therapies Production Volume Share by Type (2018-2023)

    • Figure Central China Endometriosis Therapies Production Volume Share by Type (2018-2023)

    • Table Central China Endometriosis Therapies Sales Volume by Application (2018-2023)

    • Table Central China Endometriosis Therapies Sales Volume Share by Application (2018-2023)

    • Figure Central China Endometriosis Therapies Sales Volume Share by Application (2018-2023)

    • Table South China Endometriosis Therapies Production Volume by Type (2018-2023)

    • Table South China Endometriosis Therapies Production Volume Share by Type (2018-2023)

    • Figure South China Endometriosis Therapies Production Volume Share by Type (2018-2023)

    • Table South China Endometriosis Therapies Sales Volume by Application (2018-2023)

    • Table South China Endometriosis Therapies Sales Volume Share by Application (2018-2023)

    • Figure South China Endometriosis Therapies Sales Volume Share by Application (2018-2023)

    • Table East China Endometriosis Therapies Production Volume by Type (2018-2023)

    • Table East China Endometriosis Therapies Production Volume Share by Type (2018-2023)

    • Figure East China Endometriosis Therapies Production Volume Share by Type (2018-2023)

    • Table East China Endometriosis Therapies Sales Volume by Application (2018-2023)

    • Table East China Endometriosis Therapies Sales Volume Share by Application (2018-2023)

    • Figure East China Endometriosis Therapies Sales Volume Share by Application (2018-2023)

    • Table Northeast China Endometriosis Therapies Production Volume by Type (2018-2023)

    • Table Northeast China Endometriosis Therapies Production Volume Share by Type (2018-2023)

    • Figure Northeast China Endometriosis Therapies Production Volume Share by Type (2018-2023)

    • Table Northeast China Endometriosis Therapies Sales Volume by Application (2018-2023)

    • Table Northeast China Endometriosis Therapies Sales Volume Share by Application (2018-2023)

    • Figure Northeast China Endometriosis Therapies Sales Volume Share by Application (2018-2023)

    • Table Southwest China Endometriosis Therapies Production Volume by Type (2018-2023)

    • Table Southwest China Endometriosis Therapies Production Volume Share by Type (2018-2023)

    • Figure Southwest China Endometriosis Therapies Production Volume Share by Type (2018-2023)

    • Table Southwest China Endometriosis Therapies Sales Volume by Application (2018-2023)

    • Table Southwest China Endometriosis Therapies Sales Volume Share by Application (2018-2023)

    • Figure Southwest China Endometriosis Therapies Sales Volume Share by Application (2018-2023)

    • Table Northwest China Endometriosis Therapies Production Volume by Type (2018-2023)

    • Table Northwest China Endometriosis Therapies Production Volume Share by Type (2018-2023)

    • Figure Northwest China Endometriosis Therapies Production Volume Share by Type (2018-2023)

    • Table Northwest China Endometriosis Therapies Sales Volume by Application (2018-2023)

    • Table Northwest China Endometriosis Therapies Sales Volume Share by Application (2018-2023)

    • Figure Northwest China Endometriosis Therapies Sales Volume Share by Application (2018-2023)

    • Table Neurocrine Biosciences Company Profile

    • Table Neurocrine Biosciences Endometriosis Therapies Revenue, Price and Gross (2018-2023)

    • Table Bayer Company Profile

    • Table Bayer Endometriosis Therapies Revenue, Price and Gross (2018-2023)

    • Table Pfizer Company Profile

    • Table Pfizer Endometriosis Therapies Revenue, Price and Gross (2018-2023)

    • Table AbbVie Company Profile

    • Table AbbVie Endometriosis Therapies Revenue, Price and Gross (2018-2023)

    • Table Meditrina Pharmaceuticals Company Profile

    • Table Meditrina Pharmaceuticals Endometriosis Therapies Revenue, Price and Gross (2018-2023)

    • Table Eli Lilly Company Profile

    • Table Eli Lilly Endometriosis Therapies Revenue, Price and Gross (2018-2023)

    • Table Astellas Pharma Company Profile

    • Table Astellas Pharma Endometriosis Therapies Revenue, Price and Gross (2018-2023)

    • Table Takeda Pharmaceutical Company Profile

    • Table Takeda Pharmaceutical Endometriosis Therapies Revenue, Price and Gross (2018-2023)


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US